Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 22 citing Kang: The 11482G> A polymorphism in the perilipin gene is associated with weight gain with.... (0.09 sec) 

Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in …


HJ Kim, ES Kang, DJ Kim, SH Kim, CW Ahn, … - CLINICAL ENDOCRINOLOGY-OXFORD-, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 34 - Related articles - BL Direct - All 7 versions

The role of perilipin in human obesity and insulin resistance


ES Tai, JM Ordovas - Current opinion in lipidology, 2007 - journals.lww.com
Recent findings: The mechanisms that control the storage and release of
triacylglycerides in lipid droplets are complex and poorly understood; yet, they
are likely to be crucial to the understanding of the regulation of body ...
Cited by 13 - Related articles - BL Direct - All 8 versions

Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at …

- ajcn.org
P Perez-Martinez, N Yiannakouris, J Lopez- … - American Journal of Clinical Nutrition, 2008 - Am Soc Nutrition
2 Supported by contract no. 58-1950-9-001 from the US Department of Agriculture
Research Service; grant no. U 01 HL72524 (Genetic and Environmental Determinants
of Triglycerides) from the Heart, Lung, and Blood Institute, National ...
Cited by 7 - Related articles - BL Direct - All 4 versions

Effects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in …


S Deram, CY Nicolau, P Perez-Martinez, I … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc
Results: Allele frequencies were similar to other populations, PLIN1 and PLIN4
were in linkage disequilibrium (D' = 0.999; P < 0.001). At baseline, no
anthropometric differences were observed, but minor allele A at PLIN4 was ...
Cited by 4 - Related articles - All 8 versions

LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients


ES Kang, SE Park, SJ Han, SH Kim, CM Nam, … - Molecular genetics and metabolism, 2008 - Elsevier
Lipin1 protein, a product of the LPIN1 gene, is required for normal adipose
tissue development and metabolism. Lipin1 deficiency results in immature
adipocyte development in cases of mouse fatty liver dystrophy and human ...
Cited by 5 - Related articles - All 3 versions

[PDF] Pioglitazone versus rosiglitazone: effects on lipids, lipoproteins, and apolipoproteins in …


MA Deeg, MH Tan - PPAR research, 2008 - hindawi.com
Page 1. Hindawi Publishing Corporation PPAR Research Volume 2008, Article
ID 520465, 6 pages doi:10.1155/2008/520465 Review Article ...
Cited by 3 - Related articles - View as HTML - All 11 versions

Pharmacogenetics of thiazolidinedione therapy


CL Aquilante - Pharmacogenomics, 2007 - Future Medicine
The thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor-γ
agonists and have glucose-lowering, insulin-sensitizing and anti-inflammatory
effects. TZDs are approved for the treatment of Type 2 diabetes, and have ...
Cited by 3 - Related articles - BL Direct - All 4 versions

Perilipin polymorphism interacts with dietary carbohydrates to modulate anthropometric traits …

- nutrition.org
CE Smith, KL Tucker, N Yiannakouris, B Garcia … - Journal of Nutrition, 2008 - Am Soc Nutrition
Perilipin (PLIN) is the major protein surrounding lipid droplets in adipocytes
and regulates adipocyte metabolism by modulating the interaction between lipases
and triacylglycerol stores. Associations between PLIN gene polymorphisms ...
Cited by 3 - Related articles - All 15 versions

Pharmacogenomics of metabolic effects of rosiglitazone


O Šeda, L Šedová, O Oliyarnyk, L Kazdová, … - Pharmacogenomics, 2008 - Future Medicine
* These authors contributed equally to this work. ... Introduction:
Thiazolidinediones are increasingly used drugs for the treatment of Type 2
diabetes. The individual response to thiazolidinedione therapy, ranging ...
Cited by 3 - Related articles - BL Direct - All 4 versions

Interindividual variability in oral antidiabetic drug disposition and response: the role of …


MA Pacanowski, CW Hopley, CL Aquilante - Expert Opin. Drug Metab. Toxicol., 2008 - informahealthcare.com
Background: Numerous effective oral pharmacologic therapies are available to
treat type 2 diabetes. However, a substantial number of patients do not achieve
the expected glucose-lowering response, or may be predisposed to adverse ...
Cited by 2 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google